XE-991

CAS No. 122955-42-4

XE-991( XE991 )

Catalog No. M10901 CAS No. 122955-42-4

XE-991 is a potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    XE-991
  • Note
    Research use only, not for human use.
  • Brief Description
    XE-991 is a potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.
  • Description
    XE-991 is a potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively; displays 14-fold less potency for KCNQ1+minK current with Kd of 11 uM, enhances hippocampal ACh release from rat brain slices (EC50=490 nM) and is a cognitive enhancer in vivo.Alzheimer Disease Discontinued.
  • In Vitro
    XE 991 dihydrochloride possesses an EC50 of 490 nM for enhancement of [3H]ACh release from rat brain slices, and shows good in vivo potency and duration of action.
  • In Vivo
    ——
  • Synonyms
    XE991
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer Disease

Chemical Information

  • CAS Number
    122955-42-4
  • Formula Weight
    376.45
  • Molecular Formula
    C26H20N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2(CC4=CC=NC=C4)CC5=CC=NC=C5.Cl.Cl
  • Chemical Name
    10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zaczek R, et al. J Pharmacol Exp Ther. 1998 May;285(2):724-30. 2. Wang HS, et al. Mol Pharmacol. 2000 Jun;57(6):1218-23. 3. MacVinish LJ, et al. Mol Pharmacol. 2001 Oct;60(4):753-60. 4. Yeung SY, et al. Br J Pharmacol. 2005 Oct;146(4):585-95.
molnova catalog
related products
  • GAL-021

    A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.

  • Lei-Dab 7

    High affinity, selective KCa2.2 (SK2) channel blocker (Kd = 3.8 nM). Exhibits >200-fold selectivity for KCa2.2 over KCa2.1, KCa2.3, KCa3.1, IK, Kv and Kir2.1. Increases theta-burst responses and increases LTP in rat hippocampal slices in vitro. Convulsive in vivo.

  • Levcromakalim

    Levcromakalim is an activator of the ATP-sensitive K+ channel.